SN discloses stock options for Brainomix and was a speaker with Bayer, Boehringer Ingelheim ... from Covidien Healthcare International Trading (Shanghai), Johnson & Johnson MedTech, Genesis ...

A woman, 25, with type 1 diabetes started producing insulin (blue) after a stem cell transplant and is now considered to have reversed her conditionCredit: Lennart Nilsson, Boehringer Ingelheim ...

For years, there have been bottlenecks in the medicine supply in Europe. These have worsened in recent months in Germany. Analysts say that respite is unlikely to come any time soon.

CHEN MENGZE/FOR CHINA DAILY SHANGHAI -- With the seventh China ... president and CEO of Boehringer-Ingelheim Greater China said. Mohammed Tawil noted the example of Spevigo, a therapy for treating ...

Picture: Lennart Nilsson, Boehringer Ingelheim International GmbH ... builds on a related milestone in Shanghai in April. Scientists successfully transplanted insulin-producing islets into ...

Afterwards, participants received one of the following subsequent therapies according to their assignment: participants randomised to the linagliptin plus metformin group received both linagliptin (5 ...